Immunological Heterogeneity of the RCC Microenvironment: Do Targeted Therapies Influence Immune Response?
- Published in:
- Current Oncology Reports, 2012, v. 14, n. 3, p. 230, doi. 10.1007/s11912-012-0229-9
- By:
- Publication type:
- Article
Works matching IS 15233790 AND DT 2012 AND VI 14 AND IP 3
Results: 6
1
2
Circulating Biomarkers in Advanced Renal Cell Carcinoma: Clinical Applications.
- Published in:
- Current Oncology Reports, 2012, v. 14, n. 3, p. 221, doi. 10.1007/s11912-012-0231-2
- By:
- Publication type:
- Article
3
Management of Hepatocellular Carcinoma: Beyond Sorafenib.
- Published in:
- Current Oncology Reports, 2012, v. 14, n. 3, p. 257, doi. 10.1007/s11912-012-0233-0
- By:
- Publication type:
- Article
4
Pancreatic Neuroendocrine and Carcinoid Tumors: What's New, What's Old, and What's Different?
- Published in:
- Current Oncology Reports, 2012, v. 14, n. 3, p. 249, doi. 10.1007/s11912-012-0232-1
- By:
- Publication type:
- Article
5
Toward the Non-surgical Management of Locally Advanced Rectal Cancer.
- Published in:
- Current Oncology Reports, 2012, v. 14, n. 3, p. 267, doi. 10.1007/s11912-012-0234-z
- By:
- Publication type:
- Article
6
Renal Cell Carcinoma Deep Sequencing: Recent Developments.
- Published in:
- Current Oncology Reports, 2012, v. 14, n. 3, p. 240, doi. 10.1007/s11912-012-0230-3
- By:
- Publication type:
- Article